Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Nov 22, 2024 6:15pm
TRIP/NUMI/ MDMA WAR?
with ceo/ca traders??? this is the caliber of trader you are dealing with on that platform. Childish banter. back and forth banning and scalpers arguing with each other?? SOUNDS LIKE FUN Hahahaha
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Nov 21, 2024 6:06pm
News Releases
I'm going to guess that we may not get the agreement signed and announced until after the financials are released. And we may get other news releases from now until then. Or we get
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Nov 21, 2024 4:19pm
RE:Pharmala
It's amazing how many investors begin to freak out (i.e. those on CEO) when a stock pulls back. No stock goes straight up, there's always down days and pullbacks in there too. So
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Nov 21, 2024 6:55am
Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed
A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results.
read article.
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Comment by
Chefboy69
on Nov 20, 2024 6:15am
RE:RE:Pharmala
It's very clear you're not invested here and you're looking for scalping opportunities and trading opportunities and pumping and dumping and everything else that's really truly the
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Nov 20, 2024 1:34am
RE:Pharmala
Does anybody know if Pharmala Biotech has ever been mentioned on BNN??? Has anyone phoned in about the stock? Just curious to hear what one of these analyst might say. Not sure if it'
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Nov 18, 2024 8:59pm
Pharmala
I've noticed that there is very little to no coverage of Pharmala. It's not on any stock pick lists or in newslettters. Even when you come across a Canadian top-performing list of
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Nov 18, 2024 3:28pm
RE:Financials
Pharmala's Year-End is August 31, 2024 On a venture exchange these are the filing dates: Year End Filing date is Dec 30, 2024 Q1 filing date is Jan. 29, 2025 Q2 filing date is April 29, 2025 Q3
...more
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Nov 18, 2024 12:54pm
another push forward on the TSXV
and that will be VERY BULLISH FOR THIS STOCK and all CSE/TSXv vulture stocks TSXV is almost at a 3 year break out
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Nov 16, 2024 8:33pm
Golden cross
a golden cross. IS THE MOST BULLISH CHART FORMATION POSSIBLE. i have been screaming to the ceo/ca coven of traders that they need to get the 200 MDA below the 50 MDA...well if you look closely. You
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Nov 15, 2024 4:00pm
RE:RE:New Press Release - PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
Still waiting on those institutions and the American side to take notice. Still pretty quiet on the other side of the border. MDMA may need to reach a much higher price before they appear
...more
(174)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Nov 14, 2024 1:14pm
RE:New Press Release - PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
I certainly don't mind if the stock consolidates around these price levels for a bit. More news is inevitable. Looking at other stocks in this sector both big and small, it seems to me
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 14, 2024 9:20am
New Press Release - PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License
TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), has signed a Letter...
read article.
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Nov 13, 2024 8:36pm
Can Canada’s psychedelic drug developers shake off the secto
The long, strange trip to turn psychedelic drugs into approved medicines has hit a bad batch of developments in recent months. But two Canadian-incorporated companies developing mind-altering
...more
(22)
•••
1991nightmaress
X
View Profile
View Bullboard History
Comment by
1991nightmaress
on Nov 13, 2024 11:11am
RE:so in order for scalping to happen
Now with the idle threats , or whatever that's supposed to be , there literally was half a dozen on CEO yesterday basically telling you they were trading, probably all over at "Numi"
...more
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Nov 12, 2024 10:22am
so in order for scalping to happen
there MUST BE a gap the low of the day and the high of the day. EVERY TRADER knows this. These people, THINK??? unwisely that INVESTORS fall for these Bay st/Pender street criminal games? and i
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >